Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02442817 · ClinicalTrials.gov registry record · Phase 4
Linagliptin and Mesenchymal Stem Cells: A Pilot Study
A Phase 4 study, sponsored by University of Nevada, Reno.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT02442817: Completed Phase 4 study, sponsored by University of Nevada, Reno.
NCT02442817 is a Phase 4 study that has completed, run by University of Nevada, Reno. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02442817, a Phase 4 study, has completed, sponsored by University of Nevada, Reno.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of the present study is to gather pilot data on the effects of linagliptin on the concentration of the long and short forms of SDF1-α (stromal cell-derived factor alpha) in humans, and to demonstrate the feasibility of such a study in patients with psychosis in our setting.
Interventions
- DRUG Linagliptin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-03-02 |
| Est. Completion | 2018-03-02 |
| Phase | Phase 4 |
What the finished NCT02442817 record still lists
NCT02442817 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Linagliptin is the first listed.
NCT02442817 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02442817 about?
NCT02442817 is a clinical study titled "Linagliptin and Mesenchymal Stem Cells: A Pilot Study". The purpose of the present study is to gather pilot data on the effects of linagliptin on the concentration of the long and short forms of SDF1-α (stromal cell-derived factor alpha) in humans, and to demonstrate the feasibility of such a study in patients with psychosis in our setting.
What is the current status of trial NCT02442817?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2015-03-02. Estimated completion is 2018-03-02.
What interventions are being tested in trial NCT02442817?
The interventions under investigation include: Linagliptin (DRUG).
Who is sponsoring clinical trial NCT02442817?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02442817's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI